annual net income:
-$609.69M-$400.42M(-191.34%)Summary
- As of today (September 10, 2025), ARWR annual net profit is -$609.69 million, with the most recent change of -$400.42 million (-191.34%) on September 30, 2024.
- During the last 3 years, ARWR annual net income has fallen by -$468.85 million (-332.87%).
- ARWR annual net income is now -996.94% below its all-time high of $67.97 million, reached on September 30, 2019.
Performance
ARWR Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$178.65M-$546.51M(-148.56%)Summary
- As of today (September 10, 2025), ARWR quarterly net profit is -$178.65 million, with the most recent change of -$546.51 million (-148.56%) on June 30, 2025.
- Over the past year, ARWR quarterly net income has dropped by -$4.67 million (-2.69%).
- ARWR quarterly net income is now -148.56% below its all-time high of $367.86 million, reached on March 31, 2025.
Performance
ARWR quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$159.35M-$4.67M(-3.02%)Summary
- As of today (September 10, 2025), ARWR TTM net profit is -$159.35 million, with the most recent change of -$4.67 million (-3.02%) on June 30, 2025.
- Over the past year, ARWR TTM net income has increased by +$388.01 million (+70.89%).
- ARWR TTM net income is now -334.43% below its all-time high of $67.97 million, reached on September 30, 2019.
Performance
ARWR TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ARWR Net income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -191.3% | -2.7% | +70.9% |
3 y3 years | -332.9% | -148.0% | -3.5% |
5 y5 years | -996.9% | -1212.5% | -552.7% |
ARWR Net income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -332.9% | at low | -148.6% | at low | -4.8% | +75.5% |
5 y | 5-year | -996.9% | at low | -148.6% | at low | -552.7% | +75.5% |
alltime | all time | -996.9% | at low | -148.6% | at low | -334.4% | +75.5% |
ARWR Net income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$178.65M(-148.6%) | -$159.35M(+3.0%) |
Mar 2025 | - | $367.86M(-309.9%) | -$154.68M(-76.2%) |
Dec 2024 | - | -$175.22M(+1.1%) | -$649.53M(+6.5%) |
Sep 2024 | -$609.69M(+191.3%) | -$173.34M(-0.4%) | -$609.69M(+11.4%) |
Jun 2024 | - | -$173.98M(+37.0%) | -$547.36M(+14.6%) |
Mar 2024 | - | -$127.00M(-6.2%) | -$477.51M(+57.7%) |
Dec 2023 | - | -$135.38M(+21.9%) | -$302.84M(+44.7%) |
Sep 2023 | -$209.28M(+18.6%) | -$111.02M(+6.6%) | -$209.28M(+13.6%) |
Jun 2023 | - | -$104.13M(-318.4%) | -$184.20M(+21.1%) |
Mar 2023 | - | $47.68M(-214.0%) | -$152.12M(-2.1%) |
Dec 2022 | - | -$41.81M(-51.3%) | -$155.43M(-11.9%) |
Sep 2022 | -$176.49M(+25.3%) | -$85.94M(+19.3%) | -$176.49M(+14.7%) |
Jun 2022 | - | -$72.05M(-262.4%) | -$153.93M(+37.7%) |
Mar 2022 | - | $44.37M(-170.6%) | -$111.80M(-38.9%) |
Dec 2021 | - | -$62.87M(-0.8%) | -$182.99M(+29.9%) |
Sep 2021 | -$140.85M(+66.6%) | -$63.37M(+111.8%) | -$140.85M(+11.9%) |
Jun 2021 | - | -$29.92M(+11.6%) | -$125.91M(+14.9%) |
Mar 2021 | - | -$26.82M(+29.4%) | -$109.59M(+6.8%) |
Dec 2020 | - | -$20.73M(-57.2%) | -$102.61M(+21.4%) |
Sep 2020 | -$84.55M(-224.4%) | -$48.43M(+255.8%) | -$84.55M(+246.3%) |
Jun 2020 | - | -$13.61M(-31.4%) | -$24.42M(-356.2%) |
Mar 2020 | - | -$19.84M(+641.9%) | $9.53M(-82.1%) |
Dec 2019 | - | -$2.67M(-122.8%) | $53.26M(-21.6%) |
Sep 2019 | $67.97M(-224.8%) | $11.70M(-42.4%) | $67.97M(+49.4%) |
Jun 2019 | - | $20.34M(-14.9%) | $45.51M(+375.7%) |
Mar 2019 | - | $23.90M(+98.5%) | $9.57M(-132.7%) |
Dec 2018 | - | $12.04M(-211.9%) | -$29.21M(-46.3%) |
Sep 2018 | -$54.45M(+58.4%) | -$10.76M(-31.0%) | -$54.45M(+0.1%) |
Jun 2018 | - | -$15.61M(+4.8%) | -$54.42M(+22.8%) |
Mar 2018 | - | -$14.88M(+12.8%) | -$44.33M(+24.9%) |
Dec 2017 | - | -$13.20M(+23.0%) | -$35.49M(+3.2%) |
Sep 2017 | -$34.38M(-57.9%) | -$10.73M(+94.4%) | -$34.38M(-25.0%) |
Jun 2017 | - | -$5.52M(-8.7%) | -$45.87M(-23.3%) |
Mar 2017 | - | -$6.04M(-50.0%) | -$59.77M(-19.8%) |
Dec 2016 | - | -$12.09M(-45.6%) | -$74.54M(-8.8%) |
Sep 2016 | -$81.72M(-11.1%) | -$22.22M(+14.4%) | -$81.72M(-3.0%) |
Jun 2016 | - | -$19.42M(-6.7%) | -$84.24M(+4.3%) |
Mar 2016 | - | -$20.82M(+8.1%) | -$80.76M(-8.9%) |
Dec 2015 | - | -$19.26M(-22.1%) | -$88.63M(-3.6%) |
Sep 2015 | -$91.94M(+56.6%) | -$24.74M(+55.3%) | -$91.94M(+2.6%) |
Jun 2015 | - | -$15.94M(-44.4%) | -$89.63M(+5.1%) |
Mar 2015 | - | -$28.68M(+27.1%) | -$85.32M(+20.8%) |
Dec 2014 | - | -$22.58M(+0.6%) | -$70.61M(+20.2%) |
Sep 2014 | -$58.73M(+85.2%) | -$22.43M(+92.9%) | -$58.73M(+17.2%) |
Jun 2014 | - | -$11.63M(-16.9%) | -$50.10M(+12.2%) |
Mar 2014 | - | -$13.98M(+30.9%) | -$44.65M(+18.7%) |
Dec 2013 | - | -$10.69M(-22.6%) | -$37.61M(+18.6%) |
Sep 2013 | -$31.70M(+43.4%) | -$13.81M(+123.5%) | -$31.70M(+34.9%) |
Jun 2013 | - | -$6.18M(-11.0%) | -$23.50M(-8.1%) |
Mar 2013 | - | -$6.94M(+45.2%) | -$25.56M(+5.6%) |
Dec 2012 | - | -$4.78M(-14.6%) | -$24.20M(+9.5%) |
Sep 2012 | -$22.11M | -$5.60M(-32.0%) | -$22.11M(+13.6%) |
Jun 2012 | - | -$8.24M(+47.6%) | -$19.46M(+47.8%) |
Mar 2012 | - | -$5.58M(+107.8%) | -$13.16M(+59.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | - | -$2.69M(-8.8%) | -$8.25M(+14.4%) |
Sep 2011 | -$8.79M(+19.0%) | -$2.95M(+51.5%) | -$7.21M(+9.3%) |
Jun 2011 | - | -$1.94M(+187.8%) | -$6.60M(+23.7%) |
Mar 2011 | - | -$675.60K(-59.0%) | -$5.33M(-14.3%) |
Dec 2010 | - | -$1.65M(-29.4%) | -$6.22M(-4.8%) |
Sep 2010 | -$7.38M(-61.8%) | -$2.33M(+243.9%) | -$6.54M(-14.7%) |
Jun 2010 | - | -$678.20K(-56.7%) | -$7.66M(-19.4%) |
Mar 2010 | - | -$1.57M(-20.1%) | -$9.51M(-28.1%) |
Dec 2009 | - | -$1.96M(-43.4%) | -$13.24M(-31.4%) |
Sep 2009 | -$19.31M(-43.8%) | -$3.46M(+36.8%) | -$19.31M(-21.2%) |
Jun 2009 | - | -$2.53M(-52.2%) | -$24.51M(-22.8%) |
Mar 2009 | - | -$5.29M(-34.1%) | -$31.76M(-4.7%) |
Dec 2008 | - | -$8.03M(-7.3%) | -$33.31M(+4.6%) |
Sep 2008 | -$34.38M(-6.3%) | -$8.66M(-11.5%) | -$31.85M(-7.5%) |
Jun 2008 | - | -$9.78M(+43.0%) | -$34.45M(-8.9%) |
Mar 2008 | - | -$6.84M(+4.1%) | -$37.82M(-3.2%) |
Dec 2007 | - | -$6.57M(-41.6%) | -$39.09M(+6.6%) |
Sep 2007 | -$36.68M(+80.6%) | -$11.26M(-14.5%) | -$36.68M(-1.2%) |
Jun 2007 | - | -$13.16M(+62.3%) | -$37.13M(+33.9%) |
Mar 2007 | - | -$8.11M(+94.9%) | -$27.72M(+25.2%) |
Dec 2006 | - | -$4.16M(-64.4%) | -$22.13M(+1.0%) |
Sep 2006 | -$20.31M(+197.1%) | -$11.70M(+211.7%) | -$21.91M(+111.2%) |
Jun 2006 | - | -$3.75M(+48.8%) | -$10.37M(+3.9%) |
Mar 2006 | - | -$2.52M(-35.9%) | -$9.98M(+54.3%) |
Dec 2005 | - | -$3.93M(+2299.9%) | -$6.47M(+46.8%) |
Sep 2005 | -$6.84M(+148.7%) | -$163.90K(-95.1%) | -$4.41M(-25.6%) |
Jun 2005 | - | -$3.37M(-439.4%) | -$5.93M(+82.6%) |
Mar 2005 | - | $991.50K(-153.0%) | -$3.24M(-26.5%) |
Dec 2004 | - | -$1.87M(+11.1%) | -$4.41M(+60.5%) |
Sep 2004 | -$2.75M(+2787.3%) | -$1.68M(+145.8%) | -$2.75M(+186.9%) |
Jun 2004 | - | -$684.50K(+289.1%) | -$958.20K(+192.8%) |
Mar 2004 | - | -$175.90K(-14.6%) | -$327.20K(+27.8%) |
Dec 2003 | - | -$205.90K(-290.5%) | -$256.10K(+168.7%) |
Sep 2003 | -$95.20K(-61.3%) | $108.10K(-302.1%) | -$95.30K(-53.1%) |
Jun 2003 | - | -$53.50K(-49.0%) | -$203.40K(-14.5%) |
Mar 2003 | - | -$104.80K(+132.4%) | -$238.00K(+66.0%) |
Dec 2002 | - | -$45.10K(-48.8%) | -$143.40K(-11.2%) |
Sep 2002 | -$246.20K(+32.5%) | - | - |
Jun 2002 | - | -$88.10K(+763.7%) | -$161.50K(+52.4%) |
Mar 2002 | - | -$10.20K(-83.9%) | -$106.00K(-28.0%) |
Dec 2001 | - | -$63.20K(+93.9%) | -$147.20K(+63.6%) |
Sep 2001 | -$185.80K(+35.0%) | - | - |
Jun 2001 | - | -$32.60K(-36.6%) | -$90.00K(-21.7%) |
Mar 2001 | - | -$51.40K(+26.0%) | -$115.00K(-2.3%) |
Dec 2000 | - | -$40.80K(-217.2%) | -$117.70K(-14.5%) |
Sep 2000 | -$137.60K(-62.7%) | $34.80K(-160.4%) | -$137.60K(-8.7%) |
Jun 2000 | - | -$57.60K(+6.5%) | -$150.70K(-54.4%) |
Mar 2000 | - | -$54.10K(-10.9%) | -$330.70K(+13.2%) |
Dec 1999 | - | -$60.70K(-379.7%) | -$292.20K(+26.2%) |
Sep 1999 | -$368.50K(+614.1%) | $21.70K(-109.1%) | -$231.50K(-8.6%) |
Jun 1999 | - | -$237.60K(+1423.1%) | -$253.20K(+1523.1%) |
Mar 1999 | - | -$15.60K | -$15.60K |
Sep 1998 | -$51.60K(-94.0%) | - | - |
Sep 1997 | -$854.50K | - | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual net profit?
- What is the all time high annual net income for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual net income year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly net profit?
- What is the all time high quarterly net income for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly net income year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. TTM net profit?
- What is the all time high TTM net income for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. TTM net income year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual net profit?
The current annual net income of ARWR is -$609.69M
What is the all time high annual net income for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual net profit is $67.97M
What is Arrowhead Pharmaceuticals, Inc. annual net income year-on-year change?
Over the past year, ARWR annual net profit has changed by -$400.42M (-191.34%)
What is Arrowhead Pharmaceuticals, Inc. quarterly net profit?
The current quarterly net income of ARWR is -$178.65M
What is the all time high quarterly net income for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly net profit is $367.86M
What is Arrowhead Pharmaceuticals, Inc. quarterly net income year-on-year change?
Over the past year, ARWR quarterly net profit has changed by -$4.67M (-2.69%)
What is Arrowhead Pharmaceuticals, Inc. TTM net profit?
The current TTM net income of ARWR is -$159.35M
What is the all time high TTM net income for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high TTM net profit is $67.97M
What is Arrowhead Pharmaceuticals, Inc. TTM net income year-on-year change?
Over the past year, ARWR TTM net profit has changed by +$388.01M (+70.89%)